Device Trial Radar · NCT07278986
CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer
Last checked: Nov 19, 2026Latest source record: Dec 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Oct 18, 2025
Primary completion
Oct 2027
Study completion Feb 2029
Sponsor
- Lead sponsor
- Abramson Cancer Center at Penn MedicineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 12, 2025
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The research study is being done to assess the safety and ability of an investigational drug called CYTALUX (pafolacianine) and a special camera system for the detection of cancer in patients undergoing surgical resection for endometrial cancer.
Conditions
- Endometrial Cancer
- Near Infrared Fluorescence Imaging
- CYTALUX (Pafolacianine) Injection
- Planned Diagnostic Laparoscopies
Interventions
CYTALUX™ (pafolacianine)Drug
CYTALUX™ (pafolacianine) injection and standard care laparoscopic evaluation of disease. Intraoperative imaging with Cytalux will be performed for assessment of disease detection in patients who are being evaluated to undergo surgery for endometrial cancer. Any tissues removed as part of standard of care will undergo assessment with NIR light imaging prior to and after resection. This will be then compared to gold standard histologic confirmation by pathology.
1788 4K Camera System with Advanced Imaging ModalityDevice
Combination Product
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary EndpointTime frame: 2 months after surgery
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Abramson Cancer Center at Penn Medicine
Philadelphia, Pennsylvania · Recruiting
University of Pennsylvania Gynecologic Oncology Department
Philadelphia, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.